We recently published a list of 10 Best Healthcare Stocks For Long-Term Investment. In this article, we are going to take a ...

Numerous studies have looked at the effect of probiotics on this most common form of eczema. Overall, the evidence suggests ...

Inflammatory bowel disease is a diverse disease that affects people all over the globe. This diversity in setting and treatment options makes it difficult for researchers to estimate the exact cost of ...

Positive preliminary data from all five single ascending dose (SAD) cohorts and first three completed multiple ascending dose (MAD) cohorts ...

Palisade Bio (PALI) provided an update on its ongoing Phase 1a/b study of PALI-2108 for the treatment of Ulcerative Colitis, UC. The Company ...

HOUSE, PA — Johnson & Johnson (NYSE: JNJ) announced promising topline data from its Phase 2b ANTHEM-UC clinical trial evaluating icotrokinra (JNJ-2113) as a treatment for moderately to severely active ...

IBD affects millions of Americans. It's estimated that 130,000 adults and children in New England are living with the disease ...

A new study reveals that Epstein-Barr virus (EBV) infection exacerbates ulcerative colitis (UC) by driving macrophage ...

There is insufficient evidence to support exclusive enteral nutrition as an adjunctive therapy for active ulcerative colitis, ...

In the IBD Forecast Study, physiologic data collected from wearable devices were used to successfully predict inflammatory bowel disease flares.

Findings were announced from a phase 3 trial evaluating guselkumab subcutaneous induction therapy in patients with moderately to severely active ulcerative colitis.